BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31116903)

  • 1. Label-free cervicovaginal fluid proteome profiling reflects the cervix neoplastic transformation.
    Starodubtseva NL; Brzhozovskiy AG; Bugrova AE; Kononikhin AS; Indeykina MI; Gusakov KI; Chagovets VV; Nazarova NM; Frankevich VE; Sukhikh GT; Nikolaev EN
    J Mass Spectrom; 2019 Aug; 54(8):693-703. PubMed ID: 31116903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of protein biomarkers for cervical cancer using human cervicovaginal fluid.
    Van Raemdonck GA; Tjalma WA; Coen EP; Depuydt CE; Van Ostade XW
    PLoS One; 2014; 9(9):e106488. PubMed ID: 25215525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of Antimicrobial Peptides in Cervical-Vaginal Fluid from Healthy Nonpregnant Women via an Integrated Proteome and Peptidome Analysis.
    Muytjens CMJ; Yu Y; Diamandis EP
    Proteomics; 2017 Nov; 17(21):. PubMed ID: 28941238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candidate biomarkers in the cervical vaginal fluid for the (self-)diagnosis of cervical precancer.
    Van Ostade X; Dom M; Tjalma W; Van Raemdonck G
    Arch Gynecol Obstet; 2018 Feb; 297(2):295-311. PubMed ID: 29143101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytology and high risk HPV testing in cervical cancer screening program: Outcome of 3-year follow-up in an academic institute.
    Yang J; Nolte FS; Chajewski OS; Lindsey KG; Houser PM; Pellicier J; Wang Q; Ehsani L
    Diagn Cytopathol; 2018 Jan; 46(1):22-27. PubMed ID: 29048733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive proteomic analysis of human cervical-vaginal fluid.
    Dasari S; Pereira L; Reddy AP; Michaels JE; Lu X; Jacob T; Thomas A; Rodland M; Roberts CT; Gravett MG; Nagalla SR
    J Proteome Res; 2007 Apr; 6(4):1258-68. PubMed ID: 17373839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample.
    Zhao C; Austin RM
    Cancer; 2008 Aug; 114(4):242-8. PubMed ID: 18484643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervicovaginal fluid proteomic analysis to identify potential biomarkers for preterm birth.
    Parry S; Leite R; Esplin MS; Bukowski R; Zhang H; Varner M; Andrews WW; Saade GR; Ilekis J; Reddy UM; Huang H; Sadovsky Y; Blair IA; Biggio J;
    Am J Obstet Gynecol; 2020 May; 222(5):493.e1-493.e13. PubMed ID: 31758918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p16INK4A expression in cervical premalignant and malignant lesions.
    Lambert AP; Anschau F; Schmitt VM
    Exp Mol Pathol; 2006 Apr; 80(2):192-6. PubMed ID: 16257403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MALDI imaging as a specific diagnostic tool for routine cervical cytology specimens.
    Schwamborn K; Krieg RC; Uhlig S; Ikenberg H; Wellmann A
    Int J Mol Med; 2011 Mar; 27(3):417-21. PubMed ID: 21174066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and quantification of preterm birth biomarkers in human cervicovaginal fluid by liquid chromatography/tandem mass spectrometry.
    Shah SJ; Yu KH; Sangar V; Parry SI; Blair IA
    J Proteome Res; 2009 May; 8(5):2407-17. PubMed ID: 19271751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus DNA detection in cervical specimens by hybrid capture: correlation with cytologic and histologic diagnoses of squamous intraepithelial lesions of the cervix.
    Hall S; Lörincz A; Shah F; Sherman ME; Abbas F; Paull G; Kurman RJ; Shah KV
    Gynecol Oncol; 1996 Sep; 62(3):353-9. PubMed ID: 8812532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of microbial invasion of the amniotic cavity by analysis of cervicovaginal proteins in women with preterm labor and intact membranes.
    Combs CA; Garite TJ; Lapidus JA; Lapointe JP; Gravett M; Rael J; Amon E; Baxter JK; Brady K; Clewell W; Eddleman KA; Fortunato S; Franco A; Haas DM; Heyborne K; Hickok DE; How HY; Luthy D; Miller H; Nageotte M; Pereira L; Porreco R; Robilio PA; Simhan H; Sullivan SA; Trofatter K; Westover T;
    Am J Obstet Gynecol; 2015 Apr; 212(4):482.e1-482.e12. PubMed ID: 25687566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic analysis of high-grade dysplastic cervical cells obtained from ThinPrep slides using laser capture microdissection and mass spectrometry.
    Gu Y; Wu SL; Meyer JL; Hancock WS; Burg LJ; Linder J; Hanlon DW; Karger BL
    J Proteome Res; 2007 Nov; 6(11):4256-68. PubMed ID: 17902640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shotgun Lipidomics for Differential Diagnosis of HPV-Associated Cervix Transformation.
    Starodubtseva NL; Chagovets VV; Nekrasova ME; Nazarova NM; Tokareva AO; Bourmenskaya OV; Attoeva DI; Kukaev EN; Trofimov DY; Frankevich VE; Sukhikh GT
    Metabolites; 2022 May; 12(6):. PubMed ID: 35736434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical analysis of cervical intraepithelial lesion in postmenopausal women].
    Zhang X; Guan XJ; Li JQ; Zhang LH; Yang JH
    Zhonghua Fu Chan Ke Za Zhi; 2018 Oct; 53(10):705-710. PubMed ID: 30369128
    [No Abstract]   [Full Text] [Related]  

  • 17. Proteomic analysis of cervical-vaginal fluid: identification of novel biomarkers for detection of intra-amniotic infection.
    Gravett MG; Thomas A; Schneider KA; Reddy AP; Dasari S; Jacob T; Lu X; Rodland M; Pereira L; Sadowsky DW; Roberts CT; Novy MJ; Nagalla SR
    J Proteome Res; 2007 Jan; 6(1):89-96. PubMed ID: 17203952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical MUC5B and MUC5AC are Barriers to Ascending Pathogens During Pregnancy.
    Ueda Y; Mogami H; Kawamura Y; Takakura M; Inohaya A; Yasuda E; Matsuzaka Y; Chigusa Y; Ito S; Mandai M; Kondoh E
    J Clin Endocrinol Metab; 2022 Nov; 107(11):3010-3021. PubMed ID: 36112402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variations in Progression and Regression of Precancerous Lesions of the Uterine Cervix on Cytology Testing Among Women of Different Races.
    Martingano D; Renson A; Martingano AJ; Martingano FX
    J Am Osteopath Assoc; 2018 Jan; 118(1):8-18. PubMed ID: 29309102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes of miRNA Expression Profiles from Cervical-Vaginal Fluid-Derived Exosomes in Response to HPV16 Infection.
    Wu Y; Wang X; Meng L; Li W; Li C; Li P; Xu S
    Biomed Res Int; 2020; 2020():7046894. PubMed ID: 32596357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.